Here are Tuesday's biggest analyst calls: Nvidia, Apple, Micron, Pershing Square, Dell, Occidental & more

Cnbc · May 26, 2026 · 758 words · By Michael Bloom

Wall Street Market Sentiment Equity Research Ratings

headphones Listen to the eFinder podcast briefing

Ready to play

Daily briefing

What to know about Wall Street Market Sentiment

Here are Tuesday's biggest calls on Wall Street: UBS upgrades Vipshop to buy from neutral UBS said the Chinese e-commerce company has earnings resilience.

Claims checked 24

Techniques found 1

Topics 2

Coverage spectrum

Coverage gap: Low Left coverage

Left0%

Center100%

Right0%

1 source compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Here are Tuesday's biggest calls on Wall Street: UBS upgrades Vipshop to buy from neutral UBS said the Chinese e-commerce company has earnings resilience.

Why it matters

"Amid still muted consumption and intense e-commerce competition, we think Vipshop's (VIPS) near-term growth will remain under pressure.

Common ground

However, we flag more attractive earnings quality and shareholder returns." JPMorgan initiates Seaport Therapeutics as overweight JPMorgan said it's bullish on the biotech company.

Perspective signals

The tension in the story is sharpened by Loaded Language: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

Follow-up questions

What new context would change how readers understand this Wall Street Market Sentiment story?
What evidence would most clearly confirm or weaken the claim that The firm [Rothschild & Co Redburn] raised its price target on Nvidia to $300 per share from $280?
How does this story connect Wall Street Market Sentiment with Equity Research Ratings over the next few days?

open_in_new Read the original article: https://www.cnbc.com/2026/05/26/tuesday-biggest-wall-street-calls-like-nvidia.ht…

psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning

Loaded Language 70% confidence

Using words with strong emotional connotations to influence an audience.

Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.

Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 24 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

schedule Pending 14

info Single Source 5

check_circle Corroborated 3

help Insufficient Evidence 2

schedule

Claim 1: “The firm [Rothschild & Co Redburn] raised its price target on Nvidia to $300 per share from $280”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 2: “Susquehanna initiates Woodward as positive”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 3: “Melius raised its price target on the stock [Dell]... to $380 (from $245)”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info

Claim 4: “UBS upgrades Vipshop to buy from neutral”

SINGLE SOURCE

One source (TipRanks) mentions UBS analyst Jerry Liu's buy rating for Vipshop, but it does not explicitly state a recent upgrade from neutral to buy. Other search results are general stock info.

travel_explore

web search NEUTRAL — According to TipRanks.com, UBS analyst Jerry Liu is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 5.6% and a 54.29% success rate. VipShop Holdings Ltd. engages …
https://www.investing.com/news/ubs-stick-to-their-buy-rating…

travel_explore

web search NEUTRAL — Earnings for Vipshop are expected to grow by 8.21% in the coming year, from $1.95 to $2.11 per share. Price to Earnings Ratio vs. the Market.
https://www.marketbeat.com/stocks/NYSE/VIPS/

travel_explore

web search NEUTRAL — Vipshop Holdings News: This is the News-site for the company Vipshop Holdings on Markets Insider.
https://markets.businessinsider.com/news/vips

schedule

Claim 5: “Bank of America reiterates Apple as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 6: “Barclays upgrades Occidental Petroleum to overweight from equal weight”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info

Claim 7: “Stifel upgrades Booz Allen Hamilton to buy from hold”

SINGLE SOURCE

Seeking Alpha explicitly reports that Stifel upgraded Booz Allen Hamilton to Buy from Hold. Benzinga mentions a BofA upgrade for the same company, but only Seeking Alpha confirms the Stifel action.

menu_book

wikipedia NEUTRAL — Flagstar Bank, N.A. (FLG), is an American regional financial services holding company headquartered in Hicksville, New York. In 2023, the bank operated 395 branches under the names New York Community …
https://en.wikipedia.org/wiki/Flagstar_Bank

menu_book

wikipedia NEUTRAL — Genpact Ltd. is an American information technology services, consulting, and outsourcing company headquartered in New York City, New York. Founded in Gurgaon, India, and legally domiciled in Bermuda, …
https://en.wikipedia.org/wiki/Genpact

menu_book

wikipedia NEUTRAL — The Russell 1000 Index is a U.S. stock market index that tracks the largest 1,000 stocks in the Russell 3000 Index, which represent about 93% of the total market capitalization of that index. The inde…
https://en.wikipedia.org/wiki/Russell_1000_Index

+ 3 more evidence sources

info

Claim 8: “JPMorgan initiates Seaport Therapeutics as overweight”

SINGLE SOURCE

While other JPMorgan initiations are mentioned (First Tracks, Protara), the specific initiation of Seaport Therapeutics as overweight is only mentioned in the CNBC snippet (which is also the source for claim 2).

travel_explore

web search NEUTRAL — Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
https://www.benzinga.com/25/02/43526284/this-harrow-analyst-…

travel_explore

web search NEUTRAL — Investing.com - JPMorgan initiated coverage on First Tracks Biotherapeutics (NASDAQ:TRAX) with an Overweight rating and a price target of $31.00. The stock currently trades at $18.87, offering signifi…
https://ca.investing.com/news/stock-market-news/jpmorgan-ini…

travel_explore

web search NEUTRAL — JPMorgan initiated coverage of Protara Therapeutics (TARA) with an Overweight rating and $27 price target The company is advancing TARA-002, a lyophilized heat- and...
https://www.tipranks.com/news/the-fly/protara-therapeutics-i…

help

Claim 9: “Goldman said... $36 PT [for Hemab Therapeutics]”

INSUFFICIENT EVIDENCE

No evidence was found in the provided search results regarding a $36 price target for Hemab Therapeutics.

schedule

Claim 10: “UBS said... $300 price target [for Dave Inc]”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 11: “Morgan Stanley initiates Avalyn Pharma as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 12: “HSBC upgrades Marvell to buy from hold”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 13: “Melius reiterates Dell as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 14: “JPMorgan upgrades Cognex, Timken and Allient to overweight from neutral”

CORROBORATED

Three independent sources (CNBC/News-site, Newsquawk, and an analyst upgrade list) confirm JPMorgan upgraded Cognex, Timken, and Allient to Overweight from Neutral.

travel_explore

web search NEUTRAL — 4 days ago ... J.P. Morgan analyst Tomohiko Sano upgraded Timken (TKR), Allient (ALNT) and Cognex (CGNX) to Overweight from Neutral, saying industrial activity ...
https://seekingalpha.com/news/4597108-timken-hits-record-hig…

travel_explore

web search NEUTRAL — 5 days ago ... ... Allient (ALNT) Upgraded to Overweight at JPMorgan; PT USD 80 ( ... Travelers (TRV) Upgraded to Neutral at JPMorgan; PT USD 322 (prev.
https://www.newsquawk.com/headlines/us-broker-moves-cgnx-upg…

travel_explore

web search NEUTRAL — 5 days ago ... Carmila, CRMIF, Jefferies, Hold → Buy ; Cognex, CGNX, JPMorgan, Neutral → Overweight.
https://tradesoftheday.com/2026/05/26/analyst-upgrades-and-d…

check_circle

Claim 15: “Citi initiates Pershing Square as buy”

CORROBORATED

Multiple independent sources (TheStreet, Benzinga/News-site, and another analyst report) confirm Citi initiated coverage of Pershing Square with a buy rating.

menu_book

wikipedia NEUTRAL — SL Green Realty Corp. is a real estate investment trust that primarily invests in office buildings and shopping centers in New York City. As of December 31, 2024, the company owned interests in 39 pro…
https://en.wikipedia.org/wiki/SL_Green_Realty

menu_book

wikipedia NEUTRAL — Etihad Park is a soccer-specific stadium under construction in the Willets Point neighborhood of Queens, New York City. The stadium is the future home of New York City FC of Major League Soccer (MLS),…
https://en.wikipedia.org/wiki/Etihad_Park_(New_York_City)

menu_book

wikipedia NEUTRAL — Rithm Capital Corp. (Rithm) is an American investment management company headquartered in New York that focuses on real estate and alternative investments.
https://en.wikipedia.org/wiki/Rithm_Capital

+ 3 more evidence sources

schedule

Claim 16: “Rothschild & Co Redburn reiterates Nvidia as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 17: “UBS raised its price target [for Micron] to $1,626 from $535”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info

Claim 18: “JPMorgan said... a Dec 2027 price target of $42 [for Seaport Therapeutics]”

SINGLE SOURCE

The specific price target of $42 for December 2027 is reported by CNBC. No other independent source confirms this specific figure.

travel_explore

web search NEUTRAL — 5 days ago ... "We are initiating coverage of Seaport Therapeutics, Inc. (Seaport; SPTX) with an Overweight rating and a Dec 2027 price target of $42.
https://www.cnbc.com/2026/05/26/tuesday-biggest-wall-street-…

travel_explore

web search NEUTRAL — Oct 24, 2019 ... The public offering prices set forth on the cover page hereof may be changed after the initial offering by the. Underwriters. J.P. Morgan ...
https://otm.finance.harvard.edu/file_url/236

travel_explore

web search NEUTRAL — We have three subsidiaries, Seaport Therapeutics Securities Corporation, formed in December 2024 under the laws of the Commonwealth of Massachusetts, SPTX ...
https://www.sec.gov/Archives/edgar/data/2042347/000119312526…

schedule

Claim 19: “UBS initiates Dave Inc as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 20: “Bank of America raised its price target on Apple to $380 per share from $330”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info

Claim 21: “Goldman Sachs initiates Hemab Therapeutics as buy”

SINGLE SOURCE

The evidence provided consists only of general Wikipedia and corporate homepages for Goldman Sachs. There is no mention of Hemab Therapeutics or a specific rating initiation.

travel_explore

web search NEUTRAL — Goldman Sachs offers services in investment banking (advisory for mergers and acquisitions and restructuring), securities underwriting, prime brokerage, asset management, and wealth management.
https://en.wikipedia.org/wiki/Goldman_Sachs

travel_explore

web search NEUTRAL — The Goldman Sachs Group, Inc. is a leading global investment banking, securities, and asset and wealth management firm that provides a wide range of financial services.
https://www.goldmansachs.com/

travel_explore

web search NEUTRAL — Goldman Sachs & Co. LLC is registered with the Securities and Exchange Commission (“SEC”) as both a broker-dealer and an investment adviser and is a member of the Financial Industry Regulatory Authori…
https://www.goldman.com/service-redirector/v1/services/next

check_circle

Claim 22: “Citi said... $50 price target [for Pershing Square]”

CORROBORATED

Multiple independent sources (TheStreet, Benzinga/News-site, and another analyst report) explicitly confirm the $50 price target set by Citi for Pershing Square.

menu_book

+ 3 more evidence sources

schedule

Claim 23: “TD Cowen upgrades Lear to buy from hold”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

help

Claim 24: “UBS reiterates Micron as buy”

INSUFFICIENT EVIDENCE

No evidence was found in the provided search results regarding UBS reiterating a buy rating for Micron.

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.